LeMaitre Acquires Omniflow II Biologic Graft By: Benzinga via Benzinga August 18, 2014 at 10:15 AM EDT LeMaitre Vascular, Inc. (Nasdaq: LMAT) acquired Xenotis, the manufacturer and marketer of the Omniflow II biological graft for ... Read More >> Related Stocks: Lemaitre Vascular Macy's